Clinical trial
Neoadjuvant Treatment of Breast Cancer
NCT05131893
Study timeline
Study start (estimated)2022-03-01Date precision: month
Registry last updated2021-11-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
TamoxifenDRUG · verified · RxNorm: tamoxifen
GoserelinDRUG · verified · RxNorm: goserelin
EpirubicinDRUG · verified · RxNorm: epirubicin
cyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
DocetaxelDRUG · verified · RxNorm: docetaxel
paclitaxelDRUG · verified · RxNorm: paclitaxel
trastuzumabDRUG · verified · RxNorm: trastuzumab
pertuzumabDRUG · verified · RxNorm: pertuzumab
CapecitabineDRUG · verified · RxNorm: capecitabine
Sponsors & collaborators
National Institute of Oncology, Hungarylead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05131893 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.